-
41.发明申请公开(公告)号：US20160148773A1
公开(公告)日：2016-05-26
申请号：US14903602
申请日：2014-08-11
Inventor： Moshe EINAT
CPC classification number: H01J1/30 , H01J23/06 , H01J25/025 , H01J29/04 , H01J2201/306
Abstract: Disclosed are methods and devices suitable for generating electron beams and pulses of radiation. Specifically, in some disclosed embodiments, multiple emitting electrodes of a ferroelectric emitter are sequentially activated, generating a relatively long electron beam pulse that is substantially a series of substantially consecutive short electron beam pulses generated by the sequentially-activated individual emitting electrodes.
Abstract translation: 公开了适于产生电子束和辐射脉冲的方法和装置。 具体来说，在一些公开的实施例中，铁电发射器的多个发射电极被顺序地激活，产生相对较长的电子束脉冲，其基本上是由顺序激活的单个发射电极产生的基本上连续的短电子束脉冲串。
-
公开(公告)号：US20160089349A1
公开(公告)日：2016-03-31
申请号：US14785086
申请日：2014-04-16
Inventor： Sharon ANAVI-GOFFER , Juerg GERTSCH
IPC: A61K31/138 , A61K31/085
CPC classification number: A61K31/085 , A61K31/138 , A61K31/40 , A61K31/4535 , A61K31/55 , C07C43/23
Abstract: The present invention provides cannabinoid type 2 (CB2) receptor inverse agonists for treating or ameliorating psychiatric disorders. The present invention further provides pharmaceutical compositions comprising 4′-O-methylhonokiol for treating Attention Deficit Hyperactivity Disorder (ADHD) and Tourette's syndrome.
Abstract translation: 本发明提供了用于治疗或改善精神疾病的大麻素2型（CB2）受体反向激动剂。 本发明还提供了包含用于治疗注意力缺陷多动障碍（ADHD）和图雷特氏综合征的4'-O-甲基双氢环己酮的药物组合物。
-
公开(公告)号：US20150246477A1
公开(公告)日：2015-09-03
申请号：US14427749
申请日：2013-09-12
Inventor： Edward Bormashenko , Roman Grynyov , Gilad Chaniel , Yelena Bormashenko , Genady Vayman
CPC classification number: B29C59/02 , B05D1/62 , B05D5/083 , B05D7/04 , B08B17/065 , B29C59/025 , B29C59/06 , B29C59/14 , B29C2059/023 , B29K2995/0093 , B32B3/00 , B32B2307/538 , B32B2307/728 , B32B2307/73 , Y10T428/24355
Abstract: Featured surface including a plurality of tapering protrusions, that can be hydrophobic, super hydrophobic and/or oleophobic, superoleophobic, and method for making said surfaces comprising contacting (preferably under heat and pressure) the surface material (preferably, thermoplastic material) with a mesh having micron size voids, and optionally treating the surface with plasma after removing the mesh.
Abstract translation: 特征表面包括多个锥形突起，其可以是疏水的，超疏水的和/或疏油的，疏水性的，以及用于制造所述表面的方法，包括使表面材料（优选地，热塑性材料）与网 具有微米大小的空隙，并且在除去网之后任选地用等离子体处理表面。
-
44.发明申请LIGHT FIXTURE CONNECTABLE DEVICE USEFUL FOR ESTABLISHING A NETWORK INFRASTRUCTURE 有权用于建立网络基础设施的光固定连接设备公开(公告)号：US20150237706A1
公开(公告)日：2015-08-20
申请号：US14427727
申请日：2013-09-12
Inventor： Boaz Ben-Moshe , Nir Shvalb
CPC classification number: H05B37/0272 , G01S1/68 , G01S1/70 , G01S1/725 , G01S5/30 , G01S11/16 , H01R33/945 , H01R43/26 , H04W4/025 , H04W4/043 , H04W4/33 , H04W4/80 , H05B37/0254 , H05B37/029 , Y02B20/19 , Y10T29/49117
Abstract: Disclosed are devices suitable for connection to a light fixture, that in some embodiments are useful as components of a network and/or position-determining system.
Abstract translation: 公开了适合于连接到照明灯具的装置，在一些实施例中可用作网络和/或位置确定系统的组件。
-
公开(公告)号：US20150056591A1
公开(公告)日：2015-02-26
申请号：US14387548
申请日：2013-03-31
Inventor： Ronnie Tepper , Nir Shvalb , Boaz Ben-Moshe
IPC: G09B23/28
CPC classification number: G09B23/286 , A61B10/0048 , G06T19/00 , G06T2215/16 , G06T2219/008
Abstract: Disclosed are methods and devices for simulating ultrasound procedures and for training ultrasound users. Additionally disclosed are methods and devices for simulating needle insertion procedures, such as amniocentesis procedures, and for training physicians to perform such needle insertion procedures.
Abstract translation: 公开了用于模拟超声程序和训练超声波用户的方法和装置。 另外公开了用于模拟针插入程序的方法和装置，例如羊膜穿刺术，以及训练医师执行这种针插入程序。
-
Patent Agency Ranking
公开(公告)号：US10906937B2
公开(公告)日：2021-02-02
申请号：US16299206
申请日：2019-03-12
Inventor： Albert Pinhasov , Osnat Ashur-Fabian
Abstract: Isolated peptides are disclosed. The peptide comprises an amino acid sequence selected from the group consisting of SEQ ID NOs: 1-5 and 11-15, with the proviso that the amino acid sequence does not consist of SEQ ID NO: 11, SEQ ID NO: 15 or SEQ ID NO: 1, wherein the peptide is no longer than 50 amino acids. Pharmaceutical compositions comprising same and uses thereof for treatment of diseases associated with serotonin transport and/or αVβ3 activity are also disclosed.
-
公开(公告)号：US10746781B2
公开(公告)日：2020-08-18
申请号：US15557485
申请日：2016-05-05
Inventor： Joseph B. Bernstein
IPC: G01R31/26
Abstract: A ring oscillator test circuit, includes an odd number of stages, where each stage includes a load and drive transistor connected in series at a common node. The common node of each stage is electrically connected to the drive transistor gate of the following stage, and the common node of the last stage is connected to the drive transistor gate of the first stage. A first voltage input connects to the drains of all the load transistors. A second voltage input connects to the gates of all of the load transistors. A reference voltage input connects to the sources of all of the drive transistors. At least one of the common nodes connects to a test output.
-
公开(公告)号：US20200077235A1
公开(公告)日：2020-03-05
申请号：US16669704
申请日：2019-10-31
Inventor： Boaz BEN-MOSHE , Nir SHVALB
Abstract: Disclosed are methods, assemblies and devices useful for identifying the location and/or motion of a mobile device in a specified area, for assisting in mapping a specified area and also to methods, assemblies and devices for determining a location of anchors found at fixed locations in a specified area.
-
公开(公告)号：US10478507B2
公开(公告)日：2019-11-19
申请号：US15752909
申请日：2016-10-18
Inventor： Gary Gellerman
Abstract: A molecular structure comprising a targeting moiety, a multi-functional peptide platform and a plurality of controllably released bioactive agents attached thereto is provided herein.
-
50.发明申请公开(公告)号：US20190194253A1
公开(公告)日：2019-06-27
申请号：US16299206
申请日：2019-03-12
Inventor： Albert PINHASOV , Osnat ASHUR-FABIAN
Abstract: Isolated peptides are disclosed. The peptide comprises an amino acid sequence selected from the group consisting of SEQ ID NOs: 1-5 and 11-15, with the proviso that the amino acid sequence does not consist of SEQ ID NO: 11, SEQ ID NO: 15 or SEQ ID NO: 1, wherein the peptide is no longer than 50 amino acids. Pharmaceutical compositions comprising same and uses thereof for treatment of diseases associated with serotonin transport and/or αVβ3 activity are also disclosed.
-
-
-
-
-
-
-
-
-
Search Results
78
records
(took 0.026 seconds)
